Insulin receptor (IR)-deficient pups rapidly become hyperglycemic and hyperinsulinemic and die of diabetic ketoacidosis within a few days. Immunocytochemical analysis of the endocrine pancreas revealed that IR deficiency did not alter islet morphology or the number of ␤-, ␣-, ␦-, and pancreatic polypeptide (PP) cells. The lack of IR did not result in major changes in the expression of islet hormone genes or of ␤-cell-specific marker genes encoding pancreas duodenum homeobox-containing transcription factor-1 (PDX-1), glucokinase (GCK), and GLUT2, as shown by reverse transcriptase-polymerase chain reaction analysis. The serum glucagon levels in IR-deficient and nondiabetic littermates were comparable. Finally, total insulin content in the pancreas of IR-deficient pups was gradually depleted, indicating sustained insulin secretion, not compensated for by increased insulin biosynthesis. These findings are discussed in light of recent results suggesting a role of IR in ␤-cell function. Diabetes 50 (Suppl. 1):S146-S149, 2001 S everal studies using transgenic and knockout mice have established that the development and function of pancreatic ␤-cells are controlled by a number of genes encoding specific transcription factors such as pancreas duodenum homeobox-containing transcription factor-1 (PDX-1), hormones, growth factors such as IGF-I and IGF-II and their receptors, or proteins involved in glucose sensing such as glucokinase (GCK) and the glucose transporter GLUT2 (1,2).
S
everal studies using transgenic and knockout mice have established that the development and function of pancreatic ␤-cells are controlled by a number of genes encoding specific transcription factors such as pancreas duodenum homeobox-containing transcription factor-1 (PDX-1), hormones, growth factors such as IGF-I and IGF-II and their receptors, or proteins involved in glucose sensing such as glucokinase (GCK) and the glucose transporter GLUT2 (1, 2) .
The biological effects of insulin are mediated by the insulin receptor (IR), a heterotetrameric (␣ 2 ␤ 2 ) membrane tyrosine kinase. After insulin binding, the activated IR phosphorylates docking proteins such as insulin receptor substrate (IRS)-1 or IRS-2. These adaptor proteins subsequently recruit intracellular mediators, which in turn lead to the activation of various signaling pathways (3) . Although muscle, liver, and fat tissue represent the major target tissues for the metabolic action of insulin, IR is thought to be present in most cells and its expression in the ␤-cell has also been documented (4) . Despite a number of in vivo studies of humans or animal models, the question as to whether IR expression in ␤-cells has any functional significance has remained a matter of debate for several years. It has emerged from some recent work using purified ␤-cells or ␤-cell lines that insulin action through IR might play an important autocrine role in normal ␤-cell function. This conclusion is based on the observations that insulin can stimulate insulin gene transcription as well as insulin secretion in ␤-cells (5-7). It was further shown that the signaling pathways activated by IR that lead to the transcriptional upregulation of the insulin gene involve the IRS-2/phosphatidylinositol 3-kinase/p70 S6 kinase and the calcium/calmodulindependent protein (CaM) kinase cascades (5).
We and others have previously reported that targeted disruption of the IR gene (Insr) in the mouse resulted in diabetic ketoacidosis and neonatal lethality (8, 9) . IR deficiency did not preclude the development of a pancreas with both exocrine and endocrine components. IR-deficient pups were normal at birth, but rapidly became hyperglycemic and hyperinsulinemic. To gain further insight into the role of IR in ␤-cell growth and function, we analyzed in this work the endocrine pancreas in IR-deficient pups.
RESEARCH DESIGN AND METHODS
Animals and genotyping. The generation of mice with targeted disruption of the IR gene has been described previously (8) . IR-deficient mice produced by intercrossing heterozygous null mutants could be identified by their diabetic phenotype. The nondiabetic littermates were genotyped by polymerase chain reaction (PCR) performed on tail DNA using Taq DNA polymerase (Gibco) and primers specific for the neomycin phosphotransferase gene (5Ј-GTGTTCCGG CTGTCAGCGCA-3Ј/5Ј-GTCCTGATAGCGGTCCGCCA-3Ј). The following reaction cycles were used: 95°C for 5 min, 65°C for 1 min, and 72°C for 1 min, followed by 36 cycles of 95°C for 20 s, 65°C for 30 s, and 72°C for 1 min and finally 72°C for 7 min. A PCR product of 620 bp was detected in heterozygous mutant pups. Immunocytochemistry and quantification of islet cells. The splenic part of the pancreas of newborn mice was fixed overnight in 4% paraformaldehyde, dehydrated, and embedded in paraffin. Dewaxed sections (5 µm) were first blocked for endogenous peroxidase activity by incubation in a methanol/H 2 O 2 mixture, then rehydrated and treated with proteinase K (1-4 µg/ml) at 37°C. After preincubation in goat serum, the sections were exposed to guinea pig anti-insulin (Sigma) or rabbit anti-glucagon (Dako), anti-somatostatin (Eurodiagnostica), or anti-human pancreatic polypeptide (PP) (provided by Dr. L.-I. Larsson) antibodies. Detection was by biotin-labeled goat anti-guinea pig IgG (Jackson ImmunoResearch Labs) or goat anti-rabbit IgG (Immunotech), followed by incubation with peroxidase-labeled streptavidin (DAKO) and development in diaminobenzidine-H 2 O 2 . The sections were counterstained with hematoxylin. Islet cells were quantified by counting immunopositive cells on six sections separated by more than 50 µm, followed by measurement of the surface area of the sections using Biocom VisioL@b 1000 software. Reverse transcriptase-PCR analysis of pancreatic RNAs. Total pancreatic RNA from pools of four pancreata were prepared using SV Total RNA Iso-lation System (Promega). RNA samples (100 ng) were subjected to reverse transcriptase (RT)-PCR analysis using Access RT-PCR System (Promega) according to the manufacturer's instructions. The primers and probes used to analyze insulin 1/insulin 2, glucagon, somatostatin, PP, and ␤-actin mRNA have been specified previously (10) . The primer sets and oligonucleotide probes used to analyze the transcripts for PDX-1, GCK, GLUT2, and TATA binding protein (TBP) were as follows: PDX-1, 5Ј-TCGCTGGGATCACTGGAGCA-3Ј/5Ј-GGTTCCGCTGTGTAAGCACC-3Ј and 5Ј-[ 32 P]-GACCTTTCCCGAATGGA ACC-3Ј; GCK, 5Ј-CACCCAACTGCGAAATCACC-3Ј/5Ј-CATTTGTGGGGTGTG GAGTC-3Ј and 5Ј-[
32 P]-GGGCCAGTGAAATCCAGGCA-3Ј; GLUT2, 5Ј-GAGCC AAGGACCCCGTCCTA-3Ј/5Ј-GTGAAGACCAGGACCACCCC-3Ј and 5Ј-[
32 P]-GCCCTCTGCTTCCAGTACAT-3Ј; and TBP, 5Ј-AAGAGAGCCACGGACAACTG-3Ј/5Ј-TACTGAACTGCTGGTGGGTC-3Ј and 5Ј-[ 32 P]-GAGTTGTGCAGAAGTTG GGC-3Ј. PCR reactions were run for 20 cycles for insulin 1, insulin 2, glucagon, somatostatin, PP, and ␤-actin mRNAs or 24 cycles for transcripts of PDX-1, GCK, GLUT2, and TBP, which allowed exponential coamplification at equal rate of ␤-actin or TBP mRNAs with the various gene transcripts. PCR products were run on agarose gels, transferred onto Hybond membranes, and hybridized using 32 P-labeled oligonucleotide probes. For insulin 1/ insulin 2, a unique primer pair was used for RT-PCR, and the product was digested with Msp1 before Southern blot analysis using a single 32 P-labeled oligonucleotide probe, which revealed a fragment of 71 bp for insulin 1 and of 112 bp for insulin 2. Quantification of PCR products was performed using a Phosphorimager equipped with ImageQuant software (Molecular Dynamics) and was expressed in relation to internal control. Measurement of pancreatic insulin content and serum glucagon levels. Pancreatic insulin was extracted using acid/ethanol and quantified by radioimmunoassay (RIA) (ICN Pharmaceutical). Each extract was prepared from a pool of five pancreata from newborn mice. Serum glucagon levels were measured using a glucagon RIA kit (Linco Research).
RESULTS AND DISCUSSION
Islet morphology in IR-deficient mice. Pancreatic sections from IR-deficient and wild-type animals showed similar islet morphology (Fig. 1A) . In addition, quantitative analysis revealed that the numbers of the different islet cell types were also comparable (Fig. 1B) . Thus, IR is not indispensable for islet formation and development of its various cell types.
IR and the type 1 receptor for IGFs (IGF-1R) are structurally very similar and activate common signaling pathways (11) . Recent analysis of the endocrine pancreas in IGF-1R-deficient mice revealed that the numbers of ␤-and ␣-cells were significantly reduced (12) . Thus, IGF-1R, in contrast to IR, plays a major role in the growth of the various endocrine cells. It was suggested that this growth-promoting function of IGF-1R could be achieved by IRS-2-mediated inhibition of apoptosis, because this was mimicked in mice lacking IRS-2 (12,13).
We previously reported that insulin deficiency in Ins1/Ins2 double knockout mice resulted in ␤-cell hyperplasia (10). Thus, the lack of insulin or of IR does not have the same consequence on islet cell proliferation. In adult rats, short exposure to high glucose can lead to increase in ␤-cell mass (14, 15) . However, hyperglycemia per se cannot be responsible for ␤-cell hyperplasia, since both insulin-and IR-deficient mice become hyperglycemic. An attractive hypothesis is that lack of insulin could favor IGF-II action through IR, which might stimulate cell proliferation to a greater extent than insulin itself (16) . More recently, it was reported that overexpression of IGF-II in ␤-cells in transgenic mice resulted in increased ␤-cell mass (17); it was proposed that more efficient IR activation by IGF-II could partly contribute to this effect. That IGF-II action through IR can indeed stimulate cell proliferation has been clearly demonstrated using a fibroblast cell line derived from IGF-1R-deficient mice (16) . It is also conceivable that in the absence of insulin, the existence of empty IRs might result in an increased number of IR-IGF-1R hybrid receptors that can efficiently bind IGF-I. One wonders whether these hybrid receptors, which cannot form in IR-deficient mice, may have a greater mitogenic potential (18) . IR deficiency and gene expression in endocrine pancreas. Expression of genes encoding the four islet hormones was studied by RT-PCR. The results show that IR deficiency did not lead to major changes in the expression of these genes ( Fig. 2A) . Recent studies using purified ␤-cells or ␤-cell lines provided evidence that IR is involved in glucose regulation of insulin gene transcription, the secreted insulin acting on IR present on the ␤-cell (5). This mechanism of glucose action can account for the finding that IR tyrosine phosphorylation was induced in ␤-cell lines stimulated with either glucose or insulin (19) . Also, the effect of glucose on insulin gene transcription in ␤-cell lines was abolished in the presence of insulin-signaling inhibitors that block phosphatidylinositol 3-kinase, CaM kinase, and p70 s6k (5). Furthermore, overexpression of IR in ␤-cell lines resulted in increased cellular levels of insulin mRNAs (6) . In the hyperglycemic IR-deficient pups, one might have expected to find higher levels of insulin transcripts than in normoglycemic wild-type pups. Because total insulin transcripts detected in IR-deficient and wildtype pups were comparable, this suggests that transcriptional activation of the insulin gene by high glucose might require the presence of IR on ␤-cells. To further explore this issue, we plan to achieve transgenic reconstitution of IR gene expression in ␤-cells in IR-deficient mice, which we also expect to be hyperglycemic, to see whether and to what extent the level of insulin transcripts can be increased.
We further analyzed the expression of PDX-1, a key regulator of insulin gene transcription and the proposed mediator of the glucose responsiveness of insulin gene expression (20) . In parallel with the equivalence of total insulin transcripts found in normal and mutant mice, PDX-1 gene expression was also unchanged in IR-deficient pups (Fig. 2B) . PDX-1 has also been suggested to regulate the expression of other ␤-cell-specific genes, like those for the glucose-sensing proteins GCK and GLUT2 (1). RT-PCR revealed normal levels of GCK transcripts in hyperglycemic newborn mice lacking IR (Fig. 2B) . This result is in agreement with an in vitro study showing no effect of glucose on GCK gene transcription in ␤-cells (21) . In contrast, the RNA levels of GLUT2 were slightly increased in 3-to 4-day-old pups lacking IR (Fig. 2B) , thereby confirming studies showing that hyperglycemia increases GLUT2 gene expression in ␤-cells (22) .
In line with the similar levels of glucagon transcripts observed in the mutant and wild-type mice ( Fig. 2A) , serum glucagon levels in IR-deficient pups and their nondiabetic littermates were also comparable (Fig. 3) . Thus, downregulation of glucagon secretion, which normally takes place under hyperinsulinemic and hyperglycemic conditions, was not seen in IR-deficient mice. This suggests a possible involvement of IR in the regulation of ␣-cell function. In the absence of counterregulatory insulin signaling, the normal serum glucagon levels must result in sustained glucagon action in the liver, leading to glycogen breakdown and increased ketogenesis. IR deficiency and hyperinsulinemia. Because IR-deficient mice become both hyperglycemic and hyperinsulinemic, it is interesting to understand the mechanism leading to hyperinsulinemia in these mutants, i.e., lack of clearance versus increased insulin secretion from ␤-cells. It has been documented that insulin is eliminated from the circulation upon binding to IR in target tissues (23) ; therefore, it is conceivable that reduced insulin clearance contributes to hyperinsulinemia in IR-deficient mice. However, and more importantly, insulin action through IR was also reported to play an active role in insulin secretion by ␤-cells (7). This issue was further investigated by generating mice with a ␤-cell-specific knockout of the IR gene (␤IRKO). It was shown that insulin secretion in response to glucose was impaired in these mutants (24) . In addition, ␤IRKO mice become hyperinsulinemic with age. We thus determined the total insulin content in pancreatic extracts from our hyperinsulinemic IR-deficient pups by RIA. Clearly, there exists a significant depletion of pancreatic insulin in mice lacking IR compared with wild-type controls (Fig. 4) . This depletion of insulin was greater at postnatal days 3-4, when the animals had been hyperglycemic for longer than 1 day, than in 2-day-old pups, diabetic for less than 1 day. Thus, whereas the amounts of insulin transcripts are similar in Insr -/-and wild-type pancreas, sustained insulin secretion persists in the absence of IR and actively contributes to hyperinsulinemia in hyperglycemic IR knockout mice. It will be interesting to see whether insulin depletion would be higher in IR-deficient mice in which IR gene expression has been reconstituted in ␤-cells.
